#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	2040	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2046	183.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1675	1675	T	205	T	123	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	2040	16S	1529	1529	99.93	16S.l6.c4.ctg.1	2046	183.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1409	1409	C	237	C	142	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3678	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3525	189.1	0	.	n	.	0	T695C	SNP	695	695	T	1027	1027	C	217	C	131	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3678	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3525	189.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1669	1669	A	197	A	126	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3678	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3525	189.1	0	.	n	.	0	A1638G	SNP	1638	1638	A	1970	1970	G	207	G,A	103,28	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3678	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3525	189.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2303	2303	C	190	C	123	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3678	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3525	189.1	0	.	n	.	0	C2212T	SNP	2212	2212	C	2544	2544	T	242	T,C	81,75	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3678	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3525	189.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2377	2377	A	214	A	134	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	3678	23S	2890	2890	99.83	23S.l15.c4.ctg.1	3525	189.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2929	2929	C	217	C	143	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	110	folP	855	855	100.0	folP.l15.c4.ctg.1	1313	15.8	1	SNP	p	R229S	1	.	.	685	687	AGC	791	793	AGC	23;23;22	A;G;C	14;14;14	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	340	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3168	19.4	1	SNP	p	S91F	1	.	.	271	273	TTC	551	553	TTC	14;14;14	T;T;C	10;10;10	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	340	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3168	19.4	1	SNP	p	G95N	0	.	.	283	285	GGC	563	565	GGC	20;20;21	G;G;C	12;12;14	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	340	gyrA	2751	2751	99.85	gyrA.l6.c4.ctg.1	3168	19.4	1	SNP	p	D95G	1	.	.	283	285	GGC	563	565	GGC	20;20;21	G;G;C	12;12;14	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	110	mtrR	633	633	100.0	mtrR.l6.c4.ctg.1	1316	16.9	1	SNP	p	G45D	0	.	.	133	135	GGC	490	492	GGC	32;32;32	G;G;C	20;19;20	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	70	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	653	20.5	0	.	n	.	0	A197.	DEL	197	197	A	270	270	A	32	A	23	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	294	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2778	19.6	1	SNP	p	D86N	0	.	.	256	258	GAC	425	427	GAC	36;36;37	G;A;C	23;21;23	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	294	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2778	19.6	1	SNP	p	R87I	0	.	.	259	261	CGT	428	430	CGT	35;35;34	C;G;T	23;22;22	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	294	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2778	19.6	1	SNP	p	S87R	1	.	.	259	261	CGT	428	430	CGT	35;35;34	C;G;T	23;22;22	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	294	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2778	19.6	1	SNP	p	R87W	0	.	.	259	261	CGT	428	430	CGT	35;35;34	C;G;T	23;22;22	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	294	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2778	19.6	1	SNP	p	S88P	0	.	.	262	264	TCC	431	433	TCC	34;34;34	T;C;C	23;21;23	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	266	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2858	17.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1727	1729	GGC	18;18;18	G;G;C	11;12;12	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	276	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2073	24.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1131	1133	GCA	32;33;33	G;C;A	22;22;22	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	276	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2073	24.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1134	1136	ATC	33;33;33	A;T;C	22;22;22	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	276	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2073	24.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1146	1148	GTG	36;36;36	G;T;G	24;23;23	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	276	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2073	24.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1146	1148	GTG	36;36;36	G;T;G	24;23;23	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	276	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2073	24.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1650	1652	ACC	36;36;33	A;C;C	23;24;22	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	276	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2073	24.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1704	1706	GCG	20;19;20	G;C;G	15;11;11	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	276	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2073	24.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1704	1706	GCG	20;19;20	G;C;G	15;11;11	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	276	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2073	24.2	1	SNP	p	G543S	1	.	.	1627	1629	AGC	1827	1829	AGC	16;16;16	A;G;C	11;11;10	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	276	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2073	24.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1836	1838	GGC	16;16;16	G;G;C	11;12;12	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	276	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2073	24.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1854	1856	CCG	14;13;13	C;C;G	9;8;9	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	506	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	2886	30.2	0	.	p	.	0	H251Y	NONSYN	751	753	CAT	897	899	TAT	56;56;56	T;A;T	33;34;34	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	506	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	2886	30.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1407	1409	CCG	15;15;15	C;C;G	10;11;10	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	206	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1352	27.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	333	333	C	25	C	12	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	188	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1577	22.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	342	344	GAA	38;36;37	G;A;A	23;21;23	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	188	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1577	22.8	0	.	p	.	0	K46R	NONSYN	136	138	AAA	366	368	AGA	34;36;36	A;G;A	22;24;24	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	188	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1577	22.8	1	SNP	p	D121N	1	D121N	NONSYN	361	363	GAC	591	593	AAC	23;23;23	A;A;C	16;16;15	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	188	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1577	22.8	0	.	p	.	0	N134D	NONSYN	400	402	AAT	630	632	GAT	22;22;22	G;A;T	16;16;16	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	188	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1577	22.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	753	755	TCA	19;19;19	T;C;A	13;14;13	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	188	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1577	22.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	882	884	GTC	19;19;21	G;T;C	10;12;13	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	188	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1577	22.8	0	.	p	.	0	R258H	NONSYN	772	774	CGT	1002	1004	CAT	36;35;35	C;A;T	23;22;22	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	188	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1577	22.8	0	.	p	.	0	A323V	NONSYN	967	969	GCC	1197	1199	GTC	24;24;24	G;T;C	16;16;16	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	188	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1577	22.8	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1212	1214	GCA	24;24;24	G;C;A	16;16;15	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	188	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1577	22.8	1	SNP	p	G120K	1	.	.	358	360	AAG	588	590	AAG	23;23;23	A;A;G	15;16;16	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	539	900	rpoB	4179	4179	99.95	rpoB.l15.c4.ctg.1	4625	35.7	0	.	p	.	0	Q1152H	NONSYN	3454	3456	CAG	3552	3554	CAC	34;34;34	C;A;C	24;24;24	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	86	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1275	12.7	1	SNP	p	V57M	1	.	.	169	171	ATG	483	485	ATG	36;36;36	A;T;G	19;21;21	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
